Mobile

A Phase 2 Study to Investigate the Safety and Efficacy of ABT-122 Given with Methotrexate in Subjects with Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

Update Il y a 4 ans
Reference: EUCTR2013-004019-37

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

The primary objective is to estimate the treatment effect of ABT-122 by measuring the percentage of subjects achieving American College of Rheumatology response rates (ACR20) at Week 12 and to assess the safety and tolerability of ABT-122 in subjects with active rheumatoid arthritis (RA).

Inclusion criteria

  • Rheumatoid Arthritis

Links